Status: current, Primitive. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3969941012 | Ozanimod | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3969942017 | Ozanimod (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ozanimod | Is a | Immunosuppressant | true | Inferred relationship | Some | ||
| Ozanimod | Is a | Indene | true | Inferred relationship | Some | ||
| Ozanimod | Is a | Sphingosine 1-phosphate receptor agonist | true | Inferred relationship | Some | ||
| Ozanimod | Has disposition | Sphingosine 1-phosphate receptor agonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ozanimod hydrochloride | Is modification of | True | Ozanimod | Inferred relationship | Some | |
| Ozanimod (as ozanimod hydrochloride) 230 microgram oral capsule | Has BoSS | True | Ozanimod | Inferred relationship | Some | 1 |
| Ozanimod (as ozanimod hydrochloride) 460 microgram oral capsule | Has BoSS | True | Ozanimod | Inferred relationship | Some | 1 |
| Ozanimod-containing product in oral dose form | Has active ingredient | True | Ozanimod | Inferred relationship | Some | 1 |
| Ozanimod (as ozanimod hydrochloride) 920 microgram oral capsule | Has BoSS | True | Ozanimod | Inferred relationship | Some | 1 |
| Ozanimod-containing product | Has active ingredient | True | Ozanimod | Inferred relationship | Some | 1 |
| Ozanimod only product in oral dose form | Has active ingredient | True | Ozanimod | Inferred relationship | Some | 1 |
| Ozanimod only product | Has active ingredient | True | Ozanimod | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR